Purpose: The purpose of this study was to phenotypically characterise 14 isolates and study the pan-genome of S. Uganda.
Methods: Intracellular survival of select isolates in human THP-1 macrophages was comparatively assessed using Salmonella Typhimurium. Macrophage proinflammatory cytokine and chemokine markers were quantified, post-infection. Whole genome sequencing was performed using the Illumina MiSeq platform. A high-quality reference genome for S. Uganda CFSAN006159 was generated on the Pacific Biosciences RS II platform.
Results: In THP-1 macrophages, S. Uganda CFSAN006159 recorded a < 2 Log10 reduction between 2 and 168 hours, post infection; whereas, S. Uganda CFSAN006173 recorded a < 1 Log10 reduction over the same time course. Both S. Uganda isolates persisted for seven days within human macrophages, unlike the S. Typhimurium references, which were unrecoverable. Infection with S. Uganda stimulated increased cytokine (CXCL8, IL1B and TNF) and chemokine (CCL2, CCL3 and CCL22) release, compared to the reference strain.
SPI-13, containing the lgl-ripABC operon, in addition to three uncharacterised genes, has ,currently, only been reported to be highly up-regulated within macrophages. Salmonella Uganda CFSAN006159, which has been shown, in this study, to readily survive in THP-1 macrophages, in addition to eliciting a large proinflammatory response, uniquely harbours two complete chromosomal copies of SPI-13, located approximately 460-kbp apart. Bioinformatic analyses suggests that these loci appear to have been acquired from distinct genetic lineages. This finding may contribute to the extreme pathogenicity of this isolate during infection resulting from a gene dosage effect.
Significance: Characterising the phenotypic virulence and genomic diversity of this serovar further extends our understanding of its ability to illicit a host-cell response during infection.